HV

Hunt Ventures

North America, New York, United States, New York

Description

Hunt Ventures is a venture capital firm focused on life sciences companies.

Investor Profile

Hunt Ventures has backed more than 4 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 2 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series B, Series C, Series Unknown rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Biotechnology, Health Care, Pharmaceutical.

Stage Focus

  • Series B (50%)
  • Series C (25%)
  • Series Unknown (25%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Pharmaceutical
  • Manufacturing
  • Medical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Hunt Ventures frequently co-invest with?

OrbiMed
North America, New York, United States, New York
Co-Investments: 2
Alexandria Real Estate Equities
North America, California, United States, Pasadena
Co-Investments: 2
InterWest Partners
North America, California, United States, Menlo Park
Co-Investments: 2
MPM Capital
North America, Massachusetts, United States, Boston
Co-Investments: 3
CV
North America, Texas, United States, Houston
Co-Investments: 2
Cardinal Partners
North America, New Jersey, United States, Princeton
Co-Investments: 1
Red Abbey Venture Partners
North America, Maryland, United States, Baltimore
Co-Investments: 2
Cycad Group
North America, California, United States, Santa Barbara
Co-Investments: 1
Bessemer Venture Partners
North America, California, United States, San Francisco
Co-Investments: 1
CV
North America, Minnesota, United States, Minnetonka
Co-Investments: 1

What are some of recent deals done by Hunt Ventures?

Sirtris Pharmaceuticals

Cambridge, Massachusetts, United States

Sirtris Pharmaceuticals develops small molecule drugs for the treatment of aging and metabolic diseases.

BiotechnologyHealth CarePharmaceutical
Series CApr 19, 2006
Amount Raised: $37,000,000
MacroGenics

Rockville, Maryland, United States

MacroGenics is a biotechnology company developing immunotherapeutics to prevent autoimmune disorders, cancer and infectious diseases.

BiotechnologyHealth CareManufacturing
Series BOct 15, 2004
Amount Raised: $30,500,000
Peptimmune

Cambridge, Massachusetts, United States

Peptimmune is a drug company focused on the rare skin disease pemphigus vulgaris.

BiotechnologyMedicalPharmaceutical
Series BMar 12, 2003
Amount Raised: $41,200,000
MacroGenics

Rockville, Maryland, United States

MacroGenics is a biotechnology company developing immunotherapeutics to prevent autoimmune disorders, cancer and infectious diseases.

BiotechnologyHealth CareManufacturing
Series UnknownJun 7, 2002
Amount Raised: $12,600,000